DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Novartis (NYSE: NVS)

97.40 -1.76 (-1.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $97.40 -1.77%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.90
Previous Close $99.16
Daily Range $97.39 - $98.52
52-Week Range $77.90 - $102.59
Market Cap $233.6B
P/E Ratio 26.80
Dividend (Yield) $2.72 (2.4%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,483,701
Average Daily Volume 2,408,253
Current FY EPS $5.46

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

ImmunoGen, Inc. Gets Into the Black, Accounting Wise

But it's still burning cash.

Eli Lilly's 4Q Earnings Beat, Revenue Outlook Lowered - Analyst Blog

Dr. Reddy's (RDY) Q3 Earnings Down 7% Y/Y, Revenues Up - Analyst Blog

Why Biogen Idec's Shares Skyrocketed Higher

Biogen Idec reported impressive earnings results that sent shares up more than 10%.

Stocks That Battle Cancer Were The Best-Performing Biotechs In January

Incyte's Phase III RESPONSE Data on Jakafi Published - Analyst Blog

Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog

Pharma News: Synthetic Biology Finds Path to Clinic Through Novartis

Hey Obama, how's this for precision medicine? Novartis will combine CAR-T and CRISPR/Cas9 technologies. Stem cells could get a boost, too.

Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $97.40 (-1.77%)
Current stock: NVS
JNJ $100.14 (-2.19%)
Current stock: JNJ
MRK $60.28 (-2.92%)
Current stock: MRK
GSK $44.00 (-2.57%)
Current stock: GSK